Join in June to score a special gift!

Early Findings Suggest Clinical and Lab-Based Approach Critical to Tracking Head and Neck Cancer Recurrence

September 5, 2023


Read time:

5-15 mins
Technician Blood Human Samples Screening
Presented by Health Lab

Researchers at the University of Michigan are working to develop methods to anticipate recurrence in HPV-positive head and neck cancer sooner. The study revealed clinical and technological perspectives on how to measure if recurrence is happening earlier and suggest better blood tests for monitoring. Paul Swiecicki, M.D., associate medical director, discusses how these new practices differ from current methods and future implications.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.